Cover Image
Market Research Report
Product code
996907

Global Hematology Analyzers and Reagents Market - 2021-2028

Published: | DataM Intelligence | 238 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Hematology Analyzers and Reagents Market - 2021-2028
Published: September 9, 2021
DataM Intelligence
Content info: 238 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Market Overview

The Global Hematology Analyzers and Reagents Market is expected to grow at a CAGR during the forecasting period (2021-2028).

Hematology involves the science or investigation of blood cells and coagulation. Blood testing is essential for the usual physiological symptoms, such as infections, anemia, autoimmune disorders, diabetes, and cancer. Blood analysis or examination often reveals genetic data, organ defects, viruses, and so on. Hematology analyzers are commonly available to analyze blood and blood-related issues and take the form of simple handheld photo-optical equipment, advanced diagnostic point-of-care tools, and a highly automated or complex test facility analyzer.

The global hematology analyzers and reagents market size was worth US$ XX billion in 2020 and further predicted to reach US$ XX billion by 2028, at a CAGR of XX% during the forecast period (2021-2028).

Market Dynamics

The rates for automated hematology Instruments coupled with the preferences for high-sensitivity point-of-care (POC) hematology tests are expected to drive the market for hematology analyzers and reagents during the forecast period. In addition, rapid technological advances such as the implementation of basic flow cytometry techniques and the growth of high throughput hematology analyzers are expected to have a high impact on this industry's drivers.

Technological Advancements in Hematology Analyzers

The players active in the hematology analyzers and reagents market are highly competitive and have introduced novel products and reagents in the past. For instance, in May 2020, Beckman Coulter introduced DxH 690T hematology analyzer in the US to streamline workflow and reduce downtime in medium-sized laboratories. Besides, in August 2020, IDEXX Laboratories, Inc. launched a ProCyte OneHematology Analyzer to help deliver workflows with ease and accuracy at the point of treatment. The company also confirmed plans for the global roll-out of this product by early 2021.  Besides, Sysmex unveiled an automated XN-L hematology analyzer in the US in July 2017. Later in September 2018, XS-500ix was also released on the Chinese market; the latest device is an automated hematology analyzer of the XS series. Also, Agappe Diagnostics, in partnership with L&T Technology Services Limited, launched the first indigenous hematology analyzer, Mispa Count X, in September 2020. The introduction of such new products is fuelling the growth of the market for hematology analyzers and reagents.

Lack of preference

The lack of preference, which results in a slow rate of adoption of this instrument from developing regions of the world, is a limiting factor for market development. Increased customer fears about these products' safety and efficacy in the context of recent recall by major market players.

COVID-19 Impact Analysis

With globally rising infections of COVID-19, the apprehension of the lack of vital life-saving equipment and other essential medical supplies to prevent the spread of this pandemic is also widening and providing optimal treatment for the infected. In addition, before pharmacological therapy is established, ventilators serve as a crucial treatment choice for COVID-19 patients who may need critical care. Also, there is an immediate need for rapid acceleration of a wide variety of test kits in the manufacturing process (antibody tests, self-administered, and others). The study will account for COVID-19 as a primary contributor to the industry.

Segmentation Analysis

Based on the product & service, the hematology analyzers and reagents market has been classified into hematology products and services, hemostasis products and instruments, and immunohematology products and services.

Hematology Products and Services is expected to dominate in the market during the forecast period.

The hematology product and service segment held the largest market share. The same segment is also expected to dominate the market by 2027, as it has various test volumes that help produce accurate results. In addition, these devices are commonly used in medical laboratories to detect proteins or enzymes and count blood cells to diagnose disease and genetic defects better.

Based on the application, the hematology analyzers and reagents market has been classified int anemia, blood cancer, hemorrhagic condition, infection-related conditions,  immune system-related conditions, other applications

Anemia is expected to dominate the hematology analyzers and reagents market.

The segment of anemia had the largest market share in 2019 and is also expected to dominate the market by 2027. It is a medical disorder in which the patient lacks sufficiently healthy red blood cells to bring enough oxygen to the body's tissues.

Based on the end user, the hematology analyzers and reagents market has been classified into hospital laboratories, commercial service providers, government reference laboratories, and academic and research institutes

Hospital laboratories is expected to dominate the hematology analyzers and reagents market.

The hospital laboratory segment had the highest market share. In addition, the segment is expected to dominate the market during the forecast period as blood collection and analysis instruments are commonly used in hospitals and pathology laboratories. In addition, instruments such as tubes, needles, holders, blood analyzers, and other consumables are used in the hospital for a complete blood check-up. In the laboratory, blood collected/sampled is used for clinical studies.

Geographical Analysis

Based on geography, the study analyzes the hematology analyzers and reagents market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is expected to dominate the global hematology analyzers and reagents market.

North America is held a dominant position in the global hematology analyzers and reagents market in 2019. In North America, the U.S. is expected to represent considerable growth during the forecast period. Factors attributed to the region's development include the rising incidence of patients suffering from blood disorders, the growing prevalence of target diseases, and the increasing demand for blood transfusions. Moreover, Latin America is expected to represent significant growth in terms of value during the forecast period. Growing adoption rates towards automated hematology instruments coupled with increasing preferences towards high sensitivity point-of-care (POC) hematology testing is a factor behind region growth. Additionally, the hematology analyzers and reagents market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the increasing incidence of hematologic diseases and technological advancement.

Competitive Landscape

The hematology analyzers and reagents market is highly competitive. The key hematology analyzer and reagent players which are contributing to the growth of the global market include Clinical Diagnostic Solutions, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, Bio-Rad Laboratories Inc., Abbott Laboratories, Diatron, ERBA Diagnostics Inc., EKF Diagnostics HORIBA Medical, Biosystems S.A., among others. The major players are adopting new product launch and expansion strategies for global growth in the hematology analyzers and reagents market.  

Clinical Diagnostic Solutions, Inc.

  • Overview: Clinical Diagnostic Solutions, Inc. (CDS) manufactures clinical and laboratory equipment. The company produces reagents systems, hematology analyzers, controls, and calibrators and offers consulting services. It provides total hematology solutions for the physician office laboratory, clinic, small hospital, and veterinary office markets. The company was founded in 1998. Clinical Diagnostic Solutions, Inc. is the subsidiary of Boule Diagnostics.
  • Product Portfolio: The company's portfolio comprises medonic cap piercer, medonic open vial, and medonic autoloader under the hematology analyzers product category.

Why Purchase the Report?

  • Visualize the hematology analyzers and reagents market segmentation composition by product & service, application, end user, and region, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the hematology analyzers and reagents market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of hematology analyzers and reagents market - level 3 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the critical product of all major market players

The global hematology analyzer and reagent market report would provide access to an approx. 54 market data tables, 56 figures, and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers
Table of Contents
Product Code: DMHC3188

Table of Contents

1. Hematology Analyzers and Reagents Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Hematology Analyzers and Reagents Market - Market Definition and Overview

3. Hematology Analyzers and Reagents Market - Executive Summary

  • 3.1. Market Snippet by Product & Service
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Hematology Analyzers and Reagents Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Incidence of Hematologic Diseases
      • 4.1.1.2. Technological Advancements in Hematology Analyzers
    • 4.1.2. Restraint
      • 4.1.2.1. Steep Prices of High-Tier Systems
    • 4.1.3. Impact Analysis

5. Hematology Analyzers and Reagents Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. Hematology Analyzers and Reagents Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Hematology Analyzers and Reagents Market - By Product & Service

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service Segment
  • 7.3. Market Attractiveness Index, By Product & Service Segment
    • 7.3.1. Hematology Products and Services
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Hemostasis Products and Instruments
    • 7.3.3. Immunohematology Products and Services

8. Hematology Analyzers and Reagents Market - By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Anemia
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Blood Cancer
    • 8.3.3. Hemorrhagic Conditions
    • 8.3.4. Infection Related Conditions
    • 8.3.5. Immune System Related Conditions
    • 8.3.6. Other Applications

9. Hematology Analyzers and Reagents Market - By End User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 9.3. Market Attractiveness Index, By Application Segment
    • 9.3.1. Hospital Laboratories
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Commercial Service Providers
    • 9.3.3. Government Reference Laboratories
    • 9.3.4. Academic and Research Institutes

10. Hematology Analyzers and Reagents Market - By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Hematology Analyzers and Reagents Market - Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Hematology Analyzers and Reagents Market- Company Profiles

  • 12.1. Clinical Diagnostic Solutions, Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 12.3. Danaher
  • 12.4. Bio-Rad Laboratories Inc.
  • 12.5. Abbott Laboratories
  • 12.6. Diatron
  • 12.7. ERBA Diagnostics Inc.
  • 12.8. EKF Diagnostics
  • 12.9. HORIBA Medical
  • 12.10. Biosystems S.A.

13. Hematology Analyzers and Reagents Market - Premium Insights

14. Hematology Analyzers and Reagents Market - DataM Intelligence Analysis

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us